NewGenIVF Group (Nasdaq:NIVF) Announces Share Repurchase Program

BANGKOK, Thailand — November 10, 2025 — Leads & Copy — NewGenIVF Group Limited (Nasdaq: NIVF) has announced that its Board of Directors has authorized a share repurchase program, allowing the Company to repurchase up to US$2 million of its outstanding Class A ordinary shares over the next 24 months.

The Share Repurchase Program will be implemented according to the Securities Exchange Act of 1934 and the Company’s insider trading policy.

According to NewGen, the authorized repurchase amount represents more than 50% of its current market capitalization. The company believes the current market valuation does not reflect the intrinsic value of the business and its growth trajectory.

Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen, stated that the share repurchase program sends a message to shareholders about the company’s confidence in its future and its belief that the stock is significantly undervalued. He cited recent major initiatives and commercial milestones as factors expected to unlock substantial long-term value. Mr. Siu also emphasized that the repurchase program is a prudent use of capital and demonstrates the company’s commitment to enhancing shareholder returns.

The Company is authorized to repurchase shares through open market purchases, privately negotiated transactions, or other means in accordance with applicable securities laws. The timing and actual number of shares repurchased will depend on factors such as stock price, trading volume, general business and market conditions, and the requirements under Rule 10b-18 and/or Rule 10b5-1 of the Exchange Act.

The Board will review the Share Repurchase Program periodically and may authorize adjustments to its terms and size or suspend or discontinue the program. The repurchase program will be funded using the Company’s existing cash reserves.

The Share Repurchase Program does not obligate the Company to acquire any particular number of shares and may be modified, suspended, or terminated at any time at management’s discretion.

NewGenIVF Group operates through three strategic business divisions: NewGenProperty (real estate development in the UAE), NewGenDigital (digital asset and DeFi solutions), and NewGenSup (health and longevity products and solutions). The Company’s legacy business involves providing IVF and assisted reproductive treatment services across Asia.

Investor Relations Contact:
ICR, LLC
Robin Yang
Phone: +1 (212) 537-4406
Email: Newgenivf.IR@icrinc.com

Source: NewGenIVF Group Limited

Source: NewGenIVF Group Limited

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.